Results 11 to 20 of about 8,814 (196)
Novel insights into genetics and clinics of the HNF1A-MODY [PDF]
MODY (Maturity Onset Diabetes of the Young) is a type of diabetes resulting from a pathogenic effect of gene mutations. Up to date, 13 MODY genes are known. Gene HNF1A is one of the most common causes of MODY diabetes (HNF1A-MODY; MODY3).
Valkovicova Terezia +3 more
doaj +4 more sources
Altered cortisol metabolism in individuals with HNF1A-MODY [PDF]
Objective and context: Maturity onset diabetes of the young due to variants in HNF1A (HNF1A‐MODY) is the most common form of monogenic diabetes. Individuals with HNF1A‐MODY usually have a lean phenotype which contrasts with type 2 diabetes (T2DM).
Katharine R. Owen +21 more
core +5 more sources
The Common HNF1A Variant I27L Is a Modifier of Age at Diabetes Diagnosis in Individuals With HNF1A-MODY [PDF]
This is the author accepted manuscript. The final version is available from American Diabetes Association via the DOI in this record.There is wide variation in the age at diagnosis of diabetes in individuals with Maturity-Onset Diabetes of the Young ...
Michael N. Weedon +21 more
core +3 more sources
HNF1A-MODY Mutations in Nuclear Localization Signal Impair HNF1A-Import Receptor KPNA6 Interactions
#nofulltext# --- Fareed, Fareed M. A. (Arel Author), Çapan Yalçın, Özlem (Arel Author)Mutations in hepatocyte nuclear factor (HNF)1A gene cause the most common form of Maturity-onset diabetes of the young (MODY), a monogenic subtype of diabetes mellitus.
Fareed, Fareed M. A. +8 more
core +6 more sources
Congenital hyperinsulinism due to mutations in HNF1A
Congenital hyperinsulinism is a rare but significant cause of severe and persistent hypoglycaemia in infancy. Although a biphasic phenotype of congenital hyperinsulinism in infancy followed by Maturity-Onset Diabetes of the Young (MODY) in later life has
Colclough, Kevin
core +4 more sources
Cystatin C is not a good candidate biomarker for HNF1A-MODY. [PDF]
Cystatin C is a marker of glomerular filtration rate (GFR). Its level is influenced, among the others, by CRP whose concentration is decreased in HNF1A-MODY. We hypothesized that cystatin C level might be altered in HNF1A-MODY.
James, T. J. +23 more
core +7 more sources
Variants influencing age at diagnosis of HNF1A-MODY
Background HNF1A-MODY is a monogenic form of diabetes caused by variants in the HNF1A gene. Different HNF1A variants are associated with differences in age of disease onset, but other factors are postulated to influence this trait.
Agnieszka H. Ludwig-Słomczyńska +15 more
doaj +4 more sources
Background Our previous study has demonstrated that hepatocyte nuclear factor 1α (HNF1α) exerts potent therapeutic effects on hepatocellular carcinoma (HCC).
Chen-Hong Ding +12 more
doaj +2 more sources
Treatment of young patients with HNF1A mutations (HNF1A-MODY)
Aim: Children and adolescents with a molecular diagnosis of HNF1A-MODY should be treated with oral sulfonylurea according to current International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines.
Woelfle, J. +17 more
core +3 more sources
Regulation of HNF1A in human pancreatic β-cells
HNF1A is a transcription factor important for normal pancreatic β-cell function. Heterozygous mutations in HNF1A result in monogenic diabetes. Furthermore, rare and common variants in HNF1A influence Type 2 diabetes risk.
Font Cunill, Berta
core +3 more sources

